Alto Neuroscience: Funding, Investors & Team (Oct 2026)
Alto Neuroscience aims to revolutionize psychiatry by creating individualized medications that are exceptionally efficient in accelerating patients' recovery. Our platform, powered by artificial intelligence (AI), analyzes various biomarkers such as EEG and wearable data, genetics, behavioral patterns, and more, enabling us to identify the treatment that will most likely be effective for each patient. By utilizing AI-derived brain biomarkers, our approach ensures that every patient is prescribed the appropriate Alto medication, redefining the field of psychiatry precisely when it is most crucial globally.
Alto Neuroscience has raised $272M across 4 funding rounds on record, the most recent an undisclosed round of $120M announced in Mar 2026.
That round is above the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Alto Neuroscience Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Alto Neuroscience Funding Rounds
Alto Neuroscience raised $35.0M in a Series B announced in Oct 2022.
1.1 years later, an undisclosed round of $67.0M was announced in Nov 2023.
1.9 years later, an undisclosed round of $50.0M was announced in Oct 2025.
5 months later, an undisclosed round of $120M was announced in Mar 2026.
Alto Neuroscience Founders and Leadership Team
Contact details for the Alto Neuroscience team: 1 has a LinkedIn profile.
Start 14-day free trial →Alto Neuroscience Funding Compared to Other Artificial Intelligence Startups
Alto Neuroscience's latest round of $120M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alto Neuroscience in Artificial Intelligence and Los Altos
Companies Similar to Alto Neuroscience
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Nyne is the people data company. We deploy tens of millions of autonomous agents across the open web to…
Vinci utilizes generative artificial intelligence to create hardware design. Its services cover the design,…
Siena AI is an innovative customer service platform designed specifically for commerce. It combines the…
Factory is a developer of an AI-based platform for computer codes and software engineering. Its platform…
Ocular is a Cloud and Artificial Intelligence company, backed by Y Combinator, bringing Enterprise AI and…
Ghost is a consumer hardware and software company building a private, local-first computing system for…
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial…
The EnCharge AI platform provides a reliable computing solution that enables the utilization of highly…
The hardest unsolved problem in robotics isn't perception or locomotion, it's dexterity. Tangent Robotics…
Autopoiesis Sciences creates advanced AI models that aim to enable groundbreaking scientific advancements…
Alto Neuroscience Funding FAQs
What does Alto Neuroscience do?
Alto Neuroscience aims to revolutionize psychiatry by creating individualized medications that are exceptionally efficient in accelerating patients' recovery. Our platform, powered by artificial intelligence (AI), analyzes various biomarkers such as EEG and wearable data, genetics, behavioral patterns, and more, enabling us to identify the treatment that will most likely be effective for each patient. By utilizing AI-derived brain biomarkers, our approach ensures that every patient is prescribed the appropriate Alto medication, redefining the field of psychiatry precisely when it is most crucial globally.
How much funding has Alto Neuroscience raised?
Alto Neuroscience has raised $272M across 4 rounds on record. The most recent is an undisclosed round of $120M announced in Mar 2026.
When did Alto Neuroscience last raise funding?
Alto Neuroscience's most recent funding round on record is an undisclosed round of $120M, announced in Mar 2026.
Who founded Alto Neuroscience?
FundedIQ lists Amit Etkin (Founder), Wei Wu (Founder) at Alto Neuroscience.
Where is Alto Neuroscience headquartered?
Alto Neuroscience is based in Los Altos, California, United States.
How many employees does Alto Neuroscience have?
Alto Neuroscience is in the 51-100 employee band.
How does Alto Neuroscience's funding compare to other Artificial Intelligence startups?
Alto Neuroscience's latest round of $120M is above the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,241 tracked companies over the last two years.
About FundedIQ's Alto Neuroscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alto Neuroscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.